BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/6/2020 2:43:56 PM | Browse: 1261 | Download: 2520
 |
Received |
|
2019-12-27 11:06 |
|
Peer-Review Started |
|
2019-12-27 11:12 |
|
First Decision by Editorial Office Director |
|
2020-02-14 17:43 |
|
Return for Revision |
|
2020-02-14 17:43 |
|
Revised |
|
2020-03-27 11:36 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2020-05-22 09:56 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2020-05-23 01:04 |
|
Articles in Press |
|
2020-05-23 01:04 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-06-04 07:44 |
|
Publish the Manuscript Online |
|
2020-06-06 14:43 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Immunology |
| Manuscript Type |
Review |
| Article Title |
Vaccine therapy for dysbiosis-related diseases
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Kosuke Fujimoto and Satoshi Uematsu |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant-in-Aid for Early-Career Scientists) |
19K17932 |
|
| Corresponding Author |
Satoshi Uematsu, MD, PhD, Professor, Department of Immunology and Genomics, Osaka City University Graduate School of Medicine, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, Japan. uematsu.satoshi@med.osaka-cu.ac.jp |
| Key Words |
Dysbiosis; IgA; Microbiome; Mucosal immunity; Pathobiont; Vaccine |
| Core Tip |
How to control intestinal pathogenic bacteria that mediate multifactorial diseases is a major concern worldwide. There are few methods for controlling only intestinal pathogenic bacteria; therefore, we have developed a prime–boost type, next-generation mucosal vaccine, and have used it for control of bacterial intestinal diseases. This vaccine can contribute to prevention of Clostridium ramosum-mediated obesity. Thus, this approach might be useful for protecting against microbe-associated disorders of the intestine. |
| Publish Date |
2020-06-06 14:43 |
| Citation |
Fujimoto K, Uematsu S. Vaccine therapy for dysbiosis-related diseases. World J Gastroenterol 2020; 26(21): 2758-2767 |
| URL |
https://www.wjgnet.com/1007-9327/full/v26/i21/2758.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v26.i21.2758 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
